Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women

American Journal of Clinical Nutrition

Volumn 70, Issue 2, 1999, Pages 252-260

  Gerhard, Glenn T ^a   Malinow, M Rene ^b   DeLoughery, Thomas G ^b   Evans, Adam J ^b   Sexton, Gary ^b   Connor, Sonja L ^b   Wander, Rosemary C ^b   Connor, William E ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

Black women; Coronary artery disease; Folic acid; Homocysteine; Methylenetetrahydrofolate reductase; MTHFR genotype; Multivitamins; Premenopause; Racial differences; Ready to eat cereals; Vitamin B 12; White women

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; MULTIVITAMIN;

ADULT; ARTICLE; CAUCASIAN; CEREAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FOLIC ACID BLOOD LEVEL; GENOTYPE; HUMAN; LIFESTYLE; NEGRO; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PREMENOPAUSE; RACE DIFFERENCE; VITAMIN BLOOD LEVEL;

EID: 0032766234     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn.70.2.252     Document Type: Article

References (67)

1. Garfinkel L. Cigarette smoking and coronary heart disease in blacks: comparison to whites in a prospective study. Am Heart J 1984;108:802-7.
2. US Public Health Service. Vital statistics of the United States, 1987. Vol II. Mortality, Part A. Washington, DC: National Center for Health Statistics, 1990. [DHHS publication no. (PHS) 90-1101.]
3. Sungs JFC, Harris-Booker SA, Schmid G, Ford E, Simmons B, Reed JW. Racial differences in mortality from cardiovascular disease in Atlanta, 1979-1985. J Natl Med Assoc 1992;84:259-63.
4. Gillum RF. Cardiovascular disease in the United States: an epidemiologic overview. Cardiovasc Clin 1991;21:3-16.
5. Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976-1980. Vital Health Stat 11 1987;238:1-73. [DHHS publication no. (PHS) 87-1688.]
6. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960-1991. Hypertension 1995;26:60-9.
7. Cutter GR, Burke GL, Dyer AR, et al. Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials 1991;12:1S-77S.
8. Carroll M, Sempos C, Briefel R, Gray S, Johnson C. Serum lipids of adults 20-74 years: United States, 1976-80. Vital Health Stat 11 1993;242:1-107. [DHHS publication no. (PHS) 93-1692.]
9. Brown SA, Hutchinson R, Morrisette J, et al, for the ARIC Study Group. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1139-58.
10. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324:1149-55.
11. Kang SS, Wong PWK, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-98.
12. Malinow MR. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation 1990; 81:2004-6.
13. Schwartz SM, Siscovich DS, Malinow MR, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997;96:412-7.
14. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma concentrations in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
15. Kluijtmans LAJ, van den Heuvel LPWJ, Boers GHJ, et al. Molecular genetic analysis in mild hyperhomocysteinemia - a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41.
16. Gerhard GT, Sexton G, Malinow MR, et al. Premenopausal black women have more risk factors for coronary heart disease than white women. Am J Cardiol 1998;82:1040-5.
17. Brattstrom L, Lindgren A, Israelsson B, Andersson A, Hultberg B. Homocysteine and cysteine: determinants of plasma concentrations in middle-aged and elderly subjects. J Intern Med 1994;236:633-41.
18. Connor SL, Gustafson JR, Sexton G, Becker N, Artaud-Wild S, Connor WE. The Diet Habit Survey: a new method of dietary assessment that relates to plasma cholesterol changes. J Am Diet Assoc 1992;92:41-7.
19. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr 1989;50:508-16.
20. National Research Council. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press, 1989.
21. Nicklas TA, Myers S, Berenson GS. Total nutrient intake and ready-to-eat cereal consumption of children and young adults in the Bogalusa Heart Study. Nutr Rev 1995;53:S39-45.
22. 12. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea and Febiger, 1994:402-25.
23. Phipard EF. Protein and amino acids in diets. Improvements in protein nutriture. Washington, DC: National Academy of Sciences, 1974:167-83.
24. Bostom AG, Lathrop L. Hyperhomocysteinemia in end stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52:10-20.
25. Dennis VW, Robinson K. Homocysteinemia and vascular disease in end stage renal disease. Kidney Int 1996;50:S11-7.
26. Halsted EH. Alcohol and folate interactions: clinical implications. In: Bailey LB, ed. Folate in health and disease. 1st ed. New York: Marcell Dekker, Inc, 1994:313-27.
27. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993;17:687-9.
28. Moorman PG, Hames CG, Tyroler HA. Socioeconomic status and morbidity and mortality in hypertensive blacks. Cardiovasc Clin 1991;21:179-94.
29. Angell M. Privilege and health - what is the connection? N Engl J Med 1993;329:126-7.
30. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health 1986;76:287-9.
31. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994;60:559-66.
32. Ortega RM, Lopez-Sobaler AM, Gonzalez-Gross MM, et al. Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J Am Coll Nutr 1994;13:68-72.
33. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA 1995;274:1526-33.
34. Malinow MR, Kang SS, Taylor LM, et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180-8.
35. Malinow MR, Sexton G, Auerbach M, Grosman M, Wilson D, Upson B. Homocysteinemia in daily practice: concentrations in coronary artery disease. Coron Artery Dis 1990;1:215-20.
36. Malinow MR, Neito FJ, Kruger WSD, et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 1997;17:1157-62.
37. Raiten DJ, Fisher KD. Assessment of folate methodology used in the third National Health and Nutrition Examination Survey (NHANES-III, 1988-1994). J Nutr 1995;125:1371S-98S.
38. DeLoughery TG, Evans A, Sadeghi A, et al. Common mutation in methylenetetrahydrofolate reductase: correlation with homocysteine metabolism and late-onset vascular disease. Circulation 1996;94:3074-8.
39. Schurman SJ, Perlman SA, Chamizo W. Plasma creatinine results derived from an endpoint modification of the Jaffe method. Pediatr Nephrol 1998;12:414-6.
40. Steel RGD, Torrie JH. Principles and procedures of statistics: a biometrical approach. 2nd ed. New York: McGraw-Hill Book Co, 1980.
41. Devore J, Peck R. Statistics: the exploration and analysis of data. Los Angeles: West Publishing Company, 1986.
42. Mattson DE. Statistics: difficult concepts, understandable explanations. Chicago: Bolchazy-Carducci Publishers, Inc, 1984.
43. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied linear regression models, 3rd ed. Chicago: Irving, Inc, 1989.
44. US Department of Commerce, Bureau of the Census. 1990 Census of population: social and economic characteristics. Washington, DC: US Government Printing Office, 1992.
45. US Department of Commerce, Bureau of the Census. Statistical abstract of the United States, 1993. The National Data Book. 113th ed. Washington, DC: US Government Printing Office, 1994.
46. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-81.
47. Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal medial wall thickening and plasma homocyst(e)ine in asymptomatic adults: the Atherosclerosis Risk in Communities Study. Circulation 1993;87:1107-13.
48. Blann AD. Endothelial cell damage and homocysteine. Atherosclerosis 1992;94:89-91.
49. Lentz SR, Sobey CG, Pregors DJ, et al. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia. J Clin Invest 1996;98:24-9.
50. McCully KS. Chemical pathology of homocysteine: I. Atherogenesis. Ann Clin Lab Sci 1993;23:477-93.
51. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995;274:1049-57.
52. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IM. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-8.
53. Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: effects of pyridoxine and folic acid treatment. Atherosclerosis 1990;81:51-60.
54. Ubbink JB, Vermaak WJH, Delport R, van der Merwe A, Becker PJ, Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr 1995;62:802-8.
55. The New Encyclopaedia Brittanica. 15th ed. Africa. Vol 11. Chicago: Encyclopedia Brittanica Inc, 1991:32-3.
56. The New Encyclopedia Brittanica. 15th ed. Slavery. Vol 27. Chicago: Encyclopedia Brittanica Inc, 1991:285-98.
57. Subar AF, Block G. Use of vitamin and mineral supplements: demographics and amounts of nutrients consumed. The 1987 Health Interview Survey. Am J Epidemiol 1990;132:1091-101.
58. Suitor CW, Gardner JD. Supplement use among a culturally diverse group of low-income pregnant women. J Am Diet Assoc 1990;90: 268-71.
59. Duell PB, Malinow MR. Homocyst(e)inemia and risk of atherosclerosis: a clinical approach to evaluation and management. Endocrinologist 1998;8:170-7.
60. McPhillips JB, Eaton CB, Gans KM, et al. Dietary differences in smokers and non-smokers from two southeastern New England communities. J Am Diet Assoc 1994;94:287-92.
61. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease - a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
62. Engbersen AMT, Franken DG, Boers GHJ, et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995;56:142-50.
63. Van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995;346:1070-1.
64. Jacques P, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
65. McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylenetetrahydrofolate reductase in African-Americans. Thromb Res 1996;83:195-8.
66. 6. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. 8th ed. Philadelphia: Lea and Febiger, 1994:383-94.
67. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33.